Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- befree-2016 importedOn "2016-02-19" NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_assertion wasGeneratedBy ECO_0000203 NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_assertion wasDerivedFrom befree-2016 NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_assertion SIO_000772 21406037 NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_assertion evidence source_evidence_literature NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.
- NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_assertion description "[The amplification of certain RTKs (ErbB2, c-Met and FGFR2) is associated with gastric cancer progression, but the only recently approved inhibitor is trastuzumab, ErbB2-targeting antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879621.RAe8N0aIllF-z-Q8A8iSeojJNpIH1iIHSY74qffm1o8to130_provenance.